Contract Offer
In preparing the manuscript, authors should follow the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors.
The Editorial Board can check the material using the Anti-Plagiarism system. In the case of multiple borrowings, the Editorial Board operates in accordance with COPE rules.
Flebologiya.Journal of Venous Disorders. Instructions for authors
All authors submitting a manuscript to the Editorial Board must strictly adhere to the following instructions:
1. The manuscript should be accompanied by an official application letter from the organization where the work was actually done (download blank form - MS Word .doc). It may be indicated if the article is a thesis work.
In addition, copies of authorship and innovation proposal certificates or information release authorization are required if these documents are mentioned in the text of the article or expert report.
2. SUBMISSIONS are done online through http://www.cochrane.ru. Registration is required.
We inform you that the journal certifies reviews of its reviewers on the Publons.
You can download and read the instruction for using under the link - Instruction.
Media Sphera Publishing House is a partner of Publons: https://publons.com/community/our-partners/. Publons partners with the world's publishers and leading industry organizations to recognize the contributions of expert reviewers and editors.
To submit a manuscript, please, prepare the following:
- Your manuscript itself in Microsoft Word (.doc, .docx, .rtf);
- All the figures in separate files (grouped together as a single .zip or .rar archive);
- Scanned copy of the referral signed by the head of your host organization (.pdf).
3. The first page of the manuscript should include initials and surnames of the authors, their academic degrees and current positions, the title of the publication, and organization where the work was done. Official name of the institution and governmental agency with which the authors are affiliated should be indicated in the Russian and English languages. We recommend to check the correct spelling of the institution's name on the site https://grid.ac.
4. The manuscript must be signed by all authors. It is mandatory to indicate the surname, first name and patronymic of the corresponding author, his (her) mailing address (including the postal index), electronic address, and telephone numbers. In case the authors are affiliated with different organizations, the contact information (e-mail) about each institution should be provided. You must specify the ORCID for the author who submits the article, and preferably for each author of the article. If there is no ORCID number, you need to obtain it by registering at https://orcid.org/. Publication in the journal is free.
5. Articles containing the results of clinical trials of various designs (observational, comparative, non-comparative, prospective, retrospective), with the exception of descriptions of clinical cases, will be accepted if the trial protocol was registered in one of the designated online platforms available to the public.
WARNING. Registration of the protocol on publicly available online platforms will be a prerequisite for acceptance of articles describing prospective comparative and non-comparative studies from 2021 onwards, for the rest of the works from 2022 onwards. However, when submitting an article to the Editorial Board, it should be taken into account that articles with the results of registered trials will take precedence in their consideration.
It is recommended to use the relevant section of the "Chronic Vein Diseases Register" platform (https://www.venousregistry.org/index.php?f=1&id=80) to register trial protocols related to chronic vein diseases.
It is recommended to use the appropriate section of the "Venous thromboembolic complications register" platform (https://vte.venousregistry.org/index.php?f=1&id=30) to register the trial protocols related to venous thromboembolic complications
The research protocol can also be registered on the www.clinicaltrials.gov platform.
The identifier obtained during the registration of the study should be mentioned at the end of the section "Material and methods", as well as at the end of the summary.
Example: "The trial is registered in the "Chronic Venous Disease Registry," VRCVD1.006," or "The trial is registered on the ClinicalTrials.gov platform, identifier NCT03900234.
Conducting research with the help of the platform of Russian registers, i.e. accumulation of the database in the register, is not mandatory, but such research will also have priority in consideration and publication.
6. If a publication containing the results of clinical trials of prospective comparative and non-comparative design is sent for consideration, starting from 2021, it is obligatory to provide information on the approval of the trial by the local Ethics Committee. The information should be given in the section "Material and Methods" with the announcement of the Ethics Committee protocol number and date. It is not necessary to provide approval data to the local Ethics Committee before this date. However, when submitting an article to the Editorial Board, it should be taken into account that articles with research results approved by the Ethics Committee will take precedence in the review process.
7. The length of an original paper should not exceed 15 pages (1800 characters with spaces per page), it should have a maximum of 5-6 figures.
Original articles should include the following headings.
- Introduction briefly summarizes the state of the problem, unresolved issues which justify advisability of the study. The purpose of research is need to be formulate here.
- Material and methods. This heading presents the design of research, clinical material, methods of diagnosis and/or treatment, main and additional criteria of assessment (if applicable). Methods of statistical analysis should be obligatory described.
- Results. Only the results of the study should be presented here without discussion.
- Discussion. It is reasonably to briefly summarize the main findings of research, to compare them with available literature data, to emphasize their similarities and differences. It is advisable to report possible limitations of the study.
- Conclusion. The main results of the study should be shortly summarized without numbers in this item.
- Authors’ participation. Authors’ participation in development of design of the study, collection of clinical material, analysis of data, writing text and editing should be denoted.
- Conflict of interests. All possible conflicts of interests of all authors should be reported.
- References.
8. All manuscripts should be accompanied by an abstract not to exceed 200-250 words starting with the full names of the author(s) and the title of the article.
The structured abstract should have the following labeled sections: aim of the work, materials and methods, results, and conclusion.
The abstract should briefly outline the results of the study, describe its design, groups of the patients involved, and main numerical data.
Below the abstract, include a list of keywords in the Russian and English languages.
9. The author(s) should write in clear concise Russian without departing from the scope of the article. The responsibility for all aspects of the manuscript preparation (editing and proofreading) rests with the author(s).
10. Citations in the text must be carefully checked; the titles of their sources, the year of publication, the issue number, and the number of the first page should be listed in the footnote.
11. Avoid undefined abbreviations except for the generally accepted abbreviations of chemical and mathematical quantities and terms. SI units of measurement should be used throughout the manuscript.
12. Special terms should be translated into Russian; only those generally accepted in the scientific literature should be used. Avoid transliteration of foreign words into Russian. Chemical formulas and doses should be clarified by the author(s) in marginal notes.
13. Original clinical findings should be discussed and interpreted in terms of the international CEAP classification.
14. Tables should be self-explanatory, each having a short descriptive title matching the column heads. All tabular data expressed as numeric values and percentage should be thoroughly checked by the author(s) and match the respective quantities in the text. Indicate the place of each table in the text and its number.
Signatures and all text data must be sent in Russian and English!
15. FIGURES. Each figure should be attached as a separate TIFF, JPEG or PNG image. As to figures that were created or processed using Microsoft Office tools (WORD or POWER POINT), they should be attached as separate files with corresponding extensions (.doc, .docx, .ppt). File names should be given according to figure numbers in the text (e.g., Fig-1, Fig-2a, Fig-2, etc.). Our online submission and editorial system requires that all your images were downloaded as a single .zip or .rar archive.
16. Captions for figures and photos should be grouped together at the end of the article. General descriptions and the key to abbreviations should be provided. Graph legends should explain the designation of axes and units of measurements. Micrograph captions should indicate the staining method and magnification. We insist that you send only high-quality images. Please, make sure of high image resolution and large enough letters typed in the images (remember that they should be easy to read when printed).
Captions for figures and photos, notes must be in Russian and English.
17. The reference list should be typewritten and double-spaced on a separate sheet, with each title beginning a new line and numbered consecutively throughout the article using numbers in the order in which they appear in the text; do not alphabetize the names of the authors. References to books should contain the surnames and initials of the authors, the year, the full title of the book, the city and the publisher (in parenthesis), and the number of pages. For articles in journals and volumes of collected volumes, indicate the surnames and initials of the authors of the cited paper, its full title, the title of the journal or the volume, the year, the issue number, and pages (from … to …). The names of all authors of the article should be indicated to enable their inclusion into the SCOPUS database.
References should be arranged and punctuated as follows:
Edwards A.G., Baynham S., Lees T., Mitchell D.C. Management of varicose veins: a survey of current practice by members of the Vascular Society of Great Britain and Ireland. Ann R Coll Surg Engl 2009; 91: 1: 77 – 80.
2. Савельев В.С., Кириенко А. И., Золотухин И.А., Селиверстов Е.И. Проспективное обсервационное исследование СПЕКТР: регистр пациентов с хроническими заболеваниями вен нижних конечностей. Флебология 2012; 6: 1: 4 – 9.
References to theses and conference abstracts are not included in the reference list.
References embedded in the text of the paper should be numbered using numbers in square brackets in the order of which they appear in the reference list.
The names of the authors mentioned in the text should be accompanied by the initials and included in the list of references. The names of the foreign authors should be written in the original transcription. The editors check up reference lists.
Please pay attention! The only correct form of doi-link:
https://doi.org/10.5468/ogs.2016.59.1.1
Do not use «doi:», «dx.doi.org», etc. Within the link only hyphen is used.
There is no dot after doi and URL!
18. The Editorial Border reserves the right to edit manuscripts for length and other appropriate changes.
19. Each manuscript should be accompanied by a statement that it has not been published elsewhere and that it has not been submitted simultaneously for publication elsewhere.
20. The manuscripts that are not in accordance with these instructions are returned to the authors without peer review.
21. The rules for reviewing manuscripts:
All manuscripts submitted for publication in the journal are subject to reviewing by outside reviewers.
The reviewers treat the submitted manuscripts as confidential documents strictly observing the authors’ right to non-disclosure of information contained in the manuscript before its publication. If a reviewer wishes to enlist a colleague’s help in reviewing the manuscript (also on a confidential basis), he must obtain consent of the Editorial Border.
The reviewers’ comments are sent anonymously to the authors.
Rules for finalizing the article: The author needs: - answer the question posed by following the numbering of the reviewer - indicate on which page of the text changes were made on this issue - highlight changes in the text.
The Editorial Border takes the decision to accept or reject the manuscript after all reviews are returned and the authors’ answers received.
In certain cases, the Board can refer to one or more other reviewers to address concerns regarding statistical and technical issues.
The Editorial Board continuously monitors the quality of reviews using the Russian variant of the Review Quality Instrument (Version 3.2) proposed by van Rooyen S., Black N., Godlee F. J Clin Epidemiol 1999: 52: 625-629.
22. For research articles with multiple authors, the contribution made by each author to specific items should be indicated:
- study concept and design,
- collection and treatment of the material,
- statistical data processing,
- writing the text,
- editing.
Example:
Authors: I.I. Ivanov, P.P. Petrov, S.S. Sidorov
Author’s contribution:
Study concept and design - I.I. Ivanov, S.S. Sidorov
Collection and management of the material - P.P. Petrov
Statistical treatment of the data - P.P. Petrov
Writing the text - S.S. Sidorov
Editing - I.I. Ivanov
23. Conflict of interests
All authors are requested to make a formal statement at the time of submission indicating any actual or potential conflict of interests, financial or otherwise, that might constitute an embarrassment to any of the authors.
All conflicts of interests should be reflected in the manuscript (in the footnote at the title page).
The authors are required to indicate the role of sponsors of funded studies in each of the following: design and conduct of the study; collection, management, analysis, interpretation of the data, and decision to publish the results obtained. If neither the sponsor nor the funder had such role, this should be stated.
The conflict of interests disclosure questionnaire must be completed by the authors:
Each author must respond to the following questions; an affirmative answer should be explained.
Title of the manuscript (article) .................................................
Author: .................................................
1. Have you or your close relatives ever received money, presents or other rewards from the organization, institution or company whose financial performance may be influenced by your publication (including speaking and advising fees, presents, travel expenses coverage, research grants)?
Yes/No
2. Do any of your close relatives have business dealings with the organization, institution or company whose financial performance may be influenced by your publication?
Yes/No
3. Do any of your close relatives occupy leading positions in the organization, institution or company whose financial performance may be influenced by your publication?
Yes/No
4. Do any of your close relatives own shares, have financial or other interests (excepting mutual investment funds) in the organization, institution or company whose financial performance may be influenced by your publication?
Yes/No
5. Can the results of the present publication directly or indirectly affect your award?
Yes/No
6. Are there any other potential conflicts or actual contradictions between the interests of which the Editorial Border should be aware?
Yes/No
24. Informed consent
It is prohibited to publish patient identifying information: his (her) name, initials or case record number on photographs and in illness descriptions as well as family data excepting cases of paramount scientific interest (provided the patient or his(her) parents or guardians gave the informed consent for publication). Securing informed consent should be stated in the article.
25. Human rights and animal rights
For experiments involving human subjects, the authors should identify whether they conformed to the ethical standards accepted by the committee on human experimentation of the institution where the study was carried out or by the regional committee and to the ethical standards accepted by the 1975 Helsinki Declaration and its revised version of 2000.
For experiments involving laboratory animals, the authors should identify whether they conformed to the husbandry conditions accepted at the given institution, recommendations of the national research council, and national legislation.
The manuscripts should be addressed to:
Редакция журнала «Флебология» Изд-во «Медиа Сфера», 127238 Москва, а/я 54 (Editorial Board of journal “Flebologiya”, Media Sphera Publishing House, 127238 Moscow, P.O.B. 54.)
E-mail: phlebo@mediasphera.ru hide
